MOF-on-MOF Derived Co 2 P/Ni 2 P Heterostructures for High-Performance Supercapacitors
The Journal of Physical Chemistry Letters · 10.10.2024 · 15 (40) · 10181-10189
DOI: 10.1021/acs.jpclett.4c02521 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry Letters, online erschienen am 01.10.2024. Verfasst von Honglong Qu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials and Energy, Yunnan University, Kunming 650091, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Applied Basic Research Foundation of Yunnan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Materials and Energy, Yunnan University, Kunming 650091, China.
- Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.
ORCID-Profile: Hongtao Guan, Chengjun Dong, Zongyou Yin
Förderung
- Applied Basic Research Foundation of Yunnan Province
- National Natural Science Foundation of China
Zitieren
APA
Qu, H., Liu, K., Li, Q., Cao, T., Chen, G., Guan, H., Dong, C., & Yin, Z. (2024). MOF-on-MOF Derived Co 2 P/Ni 2 P Heterostructures for High-Performance Supercapacitors. The Journal of Physical Chemistry Letters, 15(40), 10181-10189. https://doi.org/10.1021/acs.jpclett.4c02521
Vancouver
Qu H, Liu K, Li Q, Cao T, Chen G, Guan H, et al. MOF-on-MOF Derived Co 2 P/Ni 2 P Heterostructures for High-Performance Supercapacitors. The Journal of Physical Chemistry Letters. 2024;15(40):10181-10189. doi:10.1021/acs.jpclett.4c02521
BibTeX
@article{Qu2024,
author = {Qu, Honglong and Liu, Kaili and Li, Qiaolin and Cao, Tiantian and Chen, Gang and Guan, Hongtao and Dong, Chengjun and Yin, Zongyou},
title = {MOF-on-MOF Derived Co 2 P/Ni 2 P Heterostructures for High-Performance Supercapacitors},
journal = {The Journal of Physical Chemistry Letters},
year = {2024},
volume = {15},
number = {40},
pages = {10181--10189},
doi = {10.1021/acs.jpclett.4c02521}
}
EUVIMED